⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL766836 | 1.00 | — | — | |
| SCHEMBL1691327 | 1.00 | — | — | |
| SCHEMBL2198483 | 0.86 | — | — | |
| SCHEMBL2197027 | 0.86 | — | — | |
| SCHEMBL766842 | 0.84 | — | — | |
| SCHEMBL2197056 | 0.84 | GBA1 (0.32) | — | |
| SCHEMBL536463 | 0.79 | — | — | |
| SCHEMBL101449 | 0.79 | — | — | |
| SCHEMBL1458932 | 0.79 | — | — | |
| SCHEMBL1869636 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 153 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3363788-A1 | CANNABINOID RECEPTOR MODULATORS | Arena Pharmaceuticals, Inc. (US) | 2018-08-22 | — | — | EP | claimed |
| CN-107254042-A | Synthetic method of unsaturated APEO containing oxa- cycloalkane and products thereof and application | 上海台界化工有限公司 | 2017-10-17 | — | — | CN | claimed |
| US-20130165412-A1 | CANNABINOID RECEPTOR MODULATORS | ARENA PHARMACEUTICALS, INC. | 2013-06-27 | — | — | US | claimed |
| US-20120214766-A1 | CANNABINOID RECEPTOR MODULATORS | ARENA PHARMACEUTICALS, INC. | 2012-08-23 | — | — | US | claimed |
| WO-2009024825-A1 | 2-PYRAZINYLBENZIMIDAZOLE DERIVATIVES AS RECEPTOR TYROSINE KINASE INHIBITORS | ASTRAZENECA AB (SE) | 2009-02-26 | — | — | WO | claimed |
| EP-0591795-B1 | Process for hydrogenolysis of citric acid | BASF AG (DE) | 1996-01-31 | — | — | EP | claimed |
| US-5391771-A | Reacting citric acid or esters on hydrogenation catalyst in nonaqueous solvent | BASF AKTIENGESELLSCHAFT | 1995-02-21 | — | — | US | claimed |
| US-5387701-A | Acid catalysis of 3-(2-hydroxyethyl)tetrahydrofuran | BASF AKTIENGESELLSCHAFT (DE) | 1995-02-07 | — | — | US | claimed |
| EP-0591795-A1 | Process for hydrogenolysis of citric acid | BASF Aktiengesellschaft (DE) | 1994-04-13 | — | — | EP | claimed |
| JP-6228119-A | — | — | None | — | — | JP | disclosed |
| JP-6192167-A | — | — | None | — | — | JP | disclosed |
| US-20260078116-A1 | SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS | Interdict Bio, Inc. (US) | 2026-03-19 | — | — | US | disclosed |
| US-20260070932-A1 | INHIBITORS OF COMPLEMENT FACTORS AND USES THEREOF | ANNEXON INC (US) | 2026-03-12 | — | — | US | disclosed |
| CN-112566906-B | Substituted quinazolinone derivatives and their use as positive allosteric modulators of MGLUR4 | 多曼治疗学公司 | 2024-11-12 | — | — | CN | disclosed |
| US-5387701-A | Acid catalysis of 3-(2-hydroxyethyl)tetrahydrofuran | BASF AKTIENGESELLSCHAFT (DE) | 1995-02-07 | — | — | US | disclosed |
| JP-H06228119-A | PREPARATION OF 4-HYDROXYMETHYLTETRAHYDROPYRAN | BASF AG | 1994-08-16 | — | — | JP | disclosed |
| JP-H06192167-A | PREPARATION OF PROPANE-1,2,3-TRICARBOXYLIC ACID, TETRAHYDROFURFURYL ACETIC ACID AND THEIR ESTERS | BASF AG | 1994-07-12 | — | — | JP | disclosed |
| EP-0591805-A1 | Process for preparing 4-hydroxymethyl-tetrahydropyran | BASF Aktiengesellschaft (DE) | 1994-04-13 | — | — | EP | disclosed |
| EP-0591795-A1 | Process for hydrogenolysis of citric acid | BASF Aktiengesellschaft (DE) | 1994-04-13 | — | — | EP | disclosed |
| EP-0591795-A1 | Process for hydrogenolysis of citric acid | BASF Aktiengesellschaft (DE) | 1994-04-13 | — | — | EP | disclosed |